Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

IrelandBack to Ireland

Clinical trials in Dublin – page 27

443 clinical trials in Dublin, Ireland across 14 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Dublin at a glance
443
clinical trials
  • Research sites14
Type of trial
Recruitment status
Quick filters

443 trials in Dublin

Open in trial search

Respiratory tract infection

Not recruiting

Study on Nitric Oxide and Saline Nasal Sprays for Treating COVID-19 and Similar Illnesses in Primary Care Patients

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Nitric Oxide
  • Sponsor:Universitair Medisch Centrum Utrecht

Amyotrophic lateral sclerosis

Not recruiting

Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Utreloxastat
  • Sponsor:PTC Therapeutics Inc.

Prostate cancer

Not recruiting

Study of Pembrolizumab, Vibostolimab, and Belzutifan for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Merck Sharp & Dohme LLC

Plasma cell myeloma

Not recruiting

Study Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Cardiac amyloidosis

Not recruiting

Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:ALXN2220
  • Sponsor:Alexion Pharmaceuticals Inc.

Plasma cell myeloma

Not recruiting

Study on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Alnuctamab
  • Sponsor:Celgene International II S.a.r.l.

Cervix carcinoma

Not recruiting

Study on Tisotumab Vedotin, Bevacizumab, Carboplatin, and Pembrolizumab for Patients with Recurrent or Stage IVB Cervical Cancer

Registered drugNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Genmab A/S

Diffuse large B-cell lymphoma

Not recruiting

Study on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Incyte Corp.

Idiopathic pulmonary fibrosis

Not recruiting

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:BI 1015550
  • Sponsor:Boehringer Ingelheim Espana S.A.

Osteochondrodysplasia

Not recruiting

Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

InvestigationalNo placebo
Countries:IrelandIreland
  • Participants:0–17 years
  • Substances:Lonapegsomatropin
  • Sponsor:Ascendis Pharma Growth Disorders A/S

Alpha-1 antitrypsin deficiency+1

Not recruiting

Study Comparing INBRX-101 and Human Alpha1-Proteinase Inhibitor for Adults with Alpha-1 Antitrypsin Deficiency Emphysema

Registered drug
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Human ALPHA-1-PROTEINASE inhibitor immunoglobulin G fusion protein, recombinant
  • Sponsor:Sanofi AATD Inc.

Dementia Alzheimer's type

Not recruiting

Study on AVP-786 for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:IrelandIreland
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Other cities in Ireland

The busiest research cities in the country

All 16 cities in Ireland

Clinical research in Dublin

What the registry says about research in the country

01 Oncology Research

Clinical trials investigating innovative treatments for various cancer types, including non-small cell lung cancer, diffuse large B-cell lymphoma, and multiple myeloma. Studies focus on evaluating novel therapeutic combinations and immunotherapy approaches.

  • Metastatic Breast Cancer Treatment
  • Prostate Cancer Therapies
  • Lymphoma Management

Research emphasizes improving patient outcomes through targeted therapies and combination treatments.

02 Infectious Disease Prevention

Studies examining preventive measures against infectious diseases, including HIV prevention and monkeypox vaccination. Research focuses on vaccine efficacy and prophylactic treatments.

  • Pre-exposure Prophylaxis
  • Vaccine Booster Studies
  • Immunogenicity Assessment

Trials aim to enhance protection against emerging infectious diseases through innovative approaches.

03 Chronic Disease Management

Investigations into treatments for chronic conditions, including Sjögren's Disease, Ulcerative Colitis, and Hereditary Angioedema. Studies evaluate both novel therapeutics and existing treatment optimization.

  • Autoimmune Disorders
  • Inflammatory Conditions
  • Metabolic Diseases

Research focuses on improving quality of life and disease management for patients with chronic conditions.

Back to IrelandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.